Constipation, a common complaint in clinical practice, often poses diagnostic and therapeutic challenges. Its multifactorial etiology and variable presentation require a comprehensive approach for effective management. This article aims to provide a holistic viewpoint on diagnosing and treating constipation.
Constipation may be primary or secondary. Primary constipation, often idiopathic, includes conditions such as slow-transit constipation, pelvic floor dysfunction, and normal-transit constipation. Secondary constipation results from systemic diseases, neurological disorders, or as an adverse effect of certain medications. A thorough patient history and physical examination can often point towards the underlying cause.
Diagnosis begins with a detailed clinical evaluation, including a comprehensive history and physical examination. The Rome IV criteria can help identify functional constipation. If the initial evaluation is inconclusive, further investigations such as blood tests, abdominal radiography, colonoscopy, or anorectal manometry may be warranted.
Treatment strategies should be individualized, considering the etiology, severity, and patient preferences. Lifestyle modifications, including increased dietary fiber and fluid intake, regular exercise, and toilet training, form the first-line treatment. Pharmacological interventions may include bulk-forming agents, stool softeners, osmotic and stimulant laxatives. For refractory cases, newer agents like prosecretory drugs or biofeedback therapy for pelvic floor dysfunction may be considered.
Emerging evidence suggests a role for gut microbiota in constipation. Probiotics, particularly Bifidobacterium and Lactobacillus species, have shown promise in improving bowel frequency and consistency. However, more research is needed to establish their definitive role.
Constipation requires a comprehensive diagnostic and therapeutic approach, considering its multifactorial etiology and potential impact on quality of life. A detailed understanding of the underlying pathophysiology, a systematic diagnostic approach, and individualized treatment strategies are key to managing this common yet complex disorder.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation